Vifor Pharma Group appointed acting Chief Financial Officer Alexandros Sigalas and Group General Counsel Oliver P. Kronenberg as members of the Vifor Pharma Executive Committee.
Sigalas, a 13-year executive at Vifor Pharma and currently Global Head of Finance, will become acting Chief Financial Officer and succeeds Colin Bond. The Swiss citizen holds a Licentiate Degree (M.Sc.) in Accounting and Business Management from University of St. Gallen and is a Certified Public Accountant in Switzerland.
Kronenberg, a Swiss citizen, joined Vifor Pharma in 2008. Following his tenure as Group General Counsel of Galenica Group from 2013 until the successful IPO of Galenica Santé in 2017, he resumed his previous role as Group General Counsel of Vifor Pharma. He holds a PhD in law from University of Basel, an LL.M. degree from the College of Europe in Bruges, Belgium, and has completed the Finance for Executives program at INSEAD.